These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31341020)

  • 21. Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes.
    Kameyama H; Nakajima H; Nishitsuji K; Mikawa S; Uchimura K; Kobayashi N; Okuhira K; Saito H; Sakashita N
    Sci Rep; 2016 Jul; 6():30391. PubMed ID: 27464946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behavior.
    Gisonno RA; Masson T; Ramella NA; Barrera EE; Romanowski V; Tricerri MA
    Proteins; 2022 Jan; 90(1):258-269. PubMed ID: 34414600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II.
    Sawashita J; Kametani F; Hasegawa K; Tsutsumi-Yasuhara S; Zhang B; Yan J; Mori M; Naiki H; Higuchi K
    Biochim Biophys Acta; 2009 Oct; 1794(10):1517-29. PubMed ID: 19596087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.
    Arciello A; De Marco N; Del Giudice R; Guglielmi F; Pucci P; Relini A; Monti DM; Piccoli R
    J Cell Mol Med; 2011 Dec; 15(12):2652-63. PubMed ID: 21306558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the Aggregation of Apolipoprotein A-I.
    Frankel R; Sparr E; Linse S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
    Gursky O; Mei X; Atkinson D
    Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.
    Raimondi S; Guglielmi F; Giorgetti S; Di Gaetano S; Arciello A; Monti DM; Relini A; Nichino D; Doglia SM; Natalello A; Pucci P; Mangione P; Obici L; Merlini G; Stoppini M; Robustelli P; Tartaglia GG; Vendruscolo M; Dobson CM; Piccoli R; Bellotti V
    J Mol Biol; 2011 Apr; 407(3):465-76. PubMed ID: 21296086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils.
    Petrlova J; Duong T; Cochran MC; Axelsson A; Mörgelin M; Roberts LM; Lagerstedt JO
    J Lipid Res; 2012 Mar; 53(3):390-398. PubMed ID: 22184756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice.
    Sawashita J; Zhang B; Hasegawa K; Mori M; Naiki H; Kametani F; Higuchi K
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E836-45. PubMed ID: 25675489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary structure changes in ApoA-I Milano (R173C) are not accompanied by a decrease in protein stability or solubility.
    Petrlova J; Dalla-Riva J; Mörgelin M; Lindahl M; Krupinska E; Stenkula KG; Voss JC; Lagerstedt JO
    PLoS One; 2014; 9(4):e96150. PubMed ID: 24755625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes.
    Rusciano G; Pesce G; Zito G; Sasso A; Gaglione R; Del Giudice R; Piccoli R; Monti DM; Arciello A
    Biochim Biophys Acta; 2016 Apr; 1860(4):795-801. PubMed ID: 26820473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
    Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein A-I induced amyloidosis.
    Genschel J; Haas R; Pröpsting MJ; Schmidt HH
    FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.
    Morgado I; Panahi A; Burwash AG; Das M; Straub JE; Gursky O
    Biochemistry; 2018 Oct; 57(39):5738-5747. PubMed ID: 30184436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.
    Kuwabara K; Nishitsuji K; Uchimura K; Hung SC; Mizuguchi M; Nakajima H; Mikawa S; Kobayashi N; Saito H; Sakashita N
    J Biol Chem; 2015 Oct; 290(40):24210-21. PubMed ID: 26292220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Bilayer Interactions of Amyloidogenic N-Terminal Fragment of Apolipoprotein A-I Probed by Förster Resonance Energy Transfer and Molecular Dynamics Simulations.
    Gorbenko GP; Trusova V; Mizuguchi C; Saito H
    J Fluoresc; 2018 Sep; 28(5):1037-1047. PubMed ID: 30008060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping the structural transition in an amyloidogenic apolipoprotein A-I.
    Lagerstedt JO; Cavigiolio G; Roberts LM; Hong HS; Jin LW; Fitzgerald PG; Oda MN; Voss JC
    Biochemistry; 2007 Aug; 46(34):9693-9. PubMed ID: 17665932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I.
    Andreola A; Bellotti V; Giorgetti S; Mangione P; Obici L; Stoppini M; Torres J; Monzani E; Merlini G; Sunde M
    J Biol Chem; 2003 Jan; 278(4):2444-51. PubMed ID: 12421824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.